Wordt geladen...
Bone Health in Patients with Breast Cancer: Recommendations from an Evidence-Based Canadian Guideline
Bone loss is common in patients with breast cancer. Bone modifying agents (BMAs), such as bisphosphonates and denosumab, have been shown to reverse or stabilize bone loss and may be useful in the primary and metastatic settings. The purpose of this review is to provide clear evidence-based strategie...
Bewaard in:
| Gepubliceerd in: | J Clin Med |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4470150/ https://ncbi.nlm.nih.gov/pubmed/26237149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm2040283 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|